Basiliximab in Lung Transplantation: Preliminary Experience

REDUCTION OF THE OCCURRENCE OF ACUTE CELLULAR REJECTION AMONG RENAL ALLOGRAFT RECIPIENTS TREATED WITH BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2-RECEPTOR MONOCLONAL ANTIBODY1,2

Barry D. Kahan, P. R. Rajagopalan, Michael Hall · Transplantation · 1999 · 483 citations

Life Sciences, Immunology, Pharmacology +17

The registry of the international society for heart and lung transplantation: eighteenth official report—2001

Jeffrey D. Hosenpud, Leah E. Bennett, Berkeley M Keck et al. · The Journal of Heart and Lung Transplantation · 2001 · 458 citations

Medicine, Cardiology, Surgery +12

Obliterative bronchiolitis after lung and heart-lung transplantation

Ko Bando, Irvin L. Paradis, Shari L. Similo et al. · Journal of Thoracic and Cardiovascular Surgery · 1995 · 424 citations · Full text

Medicine, Internal Medicine, Surgery +14

Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: Results from a double-blind randomized placebo-controlled trial

Peter Neuhaus · Liver Transplantation · 2002 · 184 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.

V G Valentine, R.C. Robbins, Gerald J. Berry et al. · PubMed · 1996 · 157 citations

Medicine, Cardiology, Surgery +15